Apollo Hospitals Unveils Strategic Overhaul to Unlock Value in Digital Health & Pharmacy

Apollo Hospitals has announced a major restructuring move that will carve out its omnichannel pharmacy and digital health business into a separate entity, setting the stage for a direct listing within the next 18 to 21 months. Key Highlights: Shareholder Benefit: Existing shareholders will receive 195.2 shares of the new company for every 100 shares held in Apollo Hospitals. Business Scope: The new entity will consolidate Apollo 24/7, offline pharmacy operations, telehealth services, and Keimed’s distribution network into a unified platform. Financial Ambition: The combined business is targeting ₹25,000 crore in revenue by FY27, with an expected EBITDA margin of 7%. Ownership Structure: Apollo Hospitals will retain a 15% stake in the new company, ensuring continued strategic alignment.